Lexicon Pharmaceuticals Inc
LXRX
Market Cap$401.37M
Close$
$-0.39
125.4% downside
Current Fair Value
125.4% downsideOvervalued by 125.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $401.37 Million |
|---|---|
| Enterprise Value | $330.85 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.8 |
| Beta | 1.22 |
| Outstanding Shares | 246,236,753 |
| Avg 30 Day Volume | 3,232,527 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.27 |
|---|---|
| PEG | -3.59 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 274.79 |
| Enterprise Value to EBIT | -1.93 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 1.07 |
Revenue Sources
No data
ESG Score
No data